Belite Bio (BLTE) is up 16.3%, or $19.69 to $140.25.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLTE:
- Belite Bio assumed with an Overweight at Cantor Fitzgerald
- Astera initiated, Nasdaq upgraded: Wall Street’s top analyst calls
- Belite Bio initiated with a Neutral at Mizuho
- Promising Outlook for Belite Bio’s Tinlarebant Drives Buy Rating Amidst Strong Financial Position and Regulatory Support
- Belite Bio ADR’s Earnings Call: Progress Amid Rising Costs